• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动患者的综合风险降低:新兴的诊断和治疗选择。第 3 次 AFNET/EHRA 共识会议报告的执行摘要。

Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.

机构信息

Hospital of University of Münster, Münster, Germany.

出版信息

Thromb Haemost. 2011 Dec;106(6):1012-9. doi: 10.1160/TH11-07-0517. Epub 2011 Nov 2.

DOI:10.1160/TH11-07-0517
PMID:22048744
Abstract

There are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7th to 9th 2010, shortly after the release of the new ESC guidelines on AF. The conference was jointly organised by the German Atrial Fibrillation competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). This executive summary report covers four sections: 1. Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy.

摘要

心房颤动(AF)管理的几个领域正在出现令人兴奋的新进展,有望改善 AF 患者的预后。本文是对 2010 年 11 月 7 日至 9 日在索菲亚安提波利斯举行的第 3 届 AFNET/EHRA 心房颤动共识会议的会议记录的执行摘要,该会议是在新的 ESC AF 指南发布后不久举行的。会议由德国心房颤动能力网络(AFNET)和欧洲心律协会(EHRA)共同组织。本执行摘要报告涵盖四个部分:1. AF 的风险因素和风险标志物,2. AF 的病理生理分类,3. 监测的 AF 持续时间对 AF 相关结局的相关性,4. 实施更好的抗血栓治疗的观点和需求。

相似文献

1
Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.心房颤动患者的综合风险降低:新兴的诊断和治疗选择。第 3 次 AFNET/EHRA 共识会议报告的执行摘要。
Thromb Haemost. 2011 Dec;106(6):1012-9. doi: 10.1160/TH11-07-0517. Epub 2011 Nov 2.
2
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.心房颤动患者的综合风险降低:新兴的诊断和治疗选择——来自第 3 届心房颤动能力网络/欧洲心律协会共识会议的报告。
Europace. 2012 Jan;14(1):8-27. doi: 10.1093/europace/eur241. Epub 2011 Jul 26.
3
Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.早期全面管理心房颤动:第二届 AFNET-EHRA 共识会议“AF 研究视角”会议记录的执行摘要。
Eur Heart J. 2009 Dec;30(24):2969-77c. doi: 10.1093/eurheartj/ehp235.
4
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).急性冠状动脉综合征和/或经皮冠状动脉介入治疗的心房颤动患者的抗栓治疗管理:执行摘要——欧洲心脏病学会血栓形成工作组的共识文件,得到欧洲心律学会(EHRA)和欧洲经皮心血管介入协会(EAPCI)的认可。
Eur Heart J. 2010 Jun;31(11):1311-8. doi: 10.1093/eurheartj/ehq117. Epub 2010 May 6.
5
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).心房颤动伴瓣膜性心脏病的抗栓治疗:欧洲心律协会(EHRA)和欧洲心脏病学会血栓工作组的联合共识文件的执行摘要,得到 ESC 瓣膜性心脏病工作组、南非心脏协会(SA Heart)、心律学会(HRS)、亚太心律学会(APHRS)、心脏心律失常学会(Cardiac Arrhythmia Society of Southern Africa,CASSA)和拉丁美洲心脏刺激和电生理学会(SOLEACE)的认可。
Thromb Haemost. 2017 Dec;117(12):2215-2236. doi: 10.1160/TH-17-10-0709. Epub 2017 Dec 6.
6
Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.心房颤动的早期综合管理:第二届AFNET/EHRA心房颤动共识会议“心房颤动研究展望”会议纪要
Europace. 2009 Jul;11(7):860-85. doi: 10.1093/europace/eup124. Epub 2009 Jun 16.
7
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference.动态风险评估改善心房颤动患者的护理质量:第 7 次 AFNET/EHRA 共识会议。
Europace. 2021 Mar 8;23(3):329-344. doi: 10.1093/europace/euaa279.
8
Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.与心房颤动高危患者治疗不足相比,遵循指南的抗栓治疗与改善的结局相关。欧洲心房颤动调查。
Am Heart J. 2007 Jun;153(6):1006-12. doi: 10.1016/j.ahj.2007.03.008.
9
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference.早期诊断和更好的节律管理可改善房颤患者的预后:第 8 届 AFNET/EHRA 共识会议。
Europace. 2023 Feb 8;25(1):6-27. doi: 10.1093/europace/euac062.
10
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference.整合心房颤动管理的新方法:第 6 届 AFNET/EHRA 共识会议。
Europace. 2018 Mar 1;20(3):395-407. doi: 10.1093/europace/eux318.

引用本文的文献

1
Risk Analysis of Atrial Fibrillation Based on ECG Phenotypes: The RAF-ECP Study Protocol.基于心电图表型的心房颤动风险分析:RAF-ECP研究方案
Phenomics. 2024 Nov 19;4(6):617-632. doi: 10.1007/s43657-023-00151-9. eCollection 2024 Dec.
2
The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension.《2018年韩国高血压学会高血压管理指南》2022年重点更新版
Clin Hypertens. 2023 Feb 15;29(1):11. doi: 10.1186/s40885-023-00234-9.
3
Paroxysmal Atrial Fibrillation in Horses: Pathophysiology, Diagnostics and Clinical Aspects.
马的阵发性心房颤动:病理生理学、诊断与临床方面
Animals (Basel). 2022 Mar 10;12(6):698. doi: 10.3390/ani12060698.
4
Increasing use of anticoagulants in Germany and its impact on hospitalization rates for genitourinary bleeding.德国抗凝药物使用的增加及其对泌尿生殖系统出血住院率的影响。
J Thromb Thrombolysis. 2020 May;49(4):533-539. doi: 10.1007/s11239-020-02061-3.
5
2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations.2018年韩国高血压学会高血压管理指南:第三部分——特殊情况下的高血压
Clin Hypertens. 2019 Aug 1;25:19. doi: 10.1186/s40885-019-0123-y. eCollection 2019.
6
Stroke incidence and anticoagulation treatment in patients with pacemaker-detected silent atrial fibrillation.起搏器检出的无症状性心房颤动患者的卒中发生率和抗凝治疗。
PLoS One. 2018 Sep 13;13(9):e0203661. doi: 10.1371/journal.pone.0203661. eCollection 2018.
7
Beating-heart Thoracoscopic Left Atrial Appendage Exclusion in a Patient with Left atrial Thrombus.心脏跳动下胸腔镜下左心耳封堵术治疗左心房血栓患者
J Atr Fibrillation. 2017 Dec 31;10(4):1630. doi: 10.4022/jafib.1630. eCollection 2017 Dec.
8
Incorporating Stroke and Bleeding Risk Stratification Tools into Atrial Fibrillation Management Making Sense of the Alphabet Soup.将卒中与出血风险分层工具纳入心房颤动管理:解读复杂的字母组合术语
J Atr Fibrillation. 2017 Apr 30;9(6):1497. doi: 10.4022/jafib.1497. eCollection 2017 Apr-May.
9
CHADS and CHADSVasc-Score in Peripheral Systemic Embolism.外周系统性栓塞中的CHADS和CHADSVasc评分
J Atr Fibrillation. 2013 Jun 30;6(1):715. doi: 10.4022/jafib.715. eCollection 2013 Jun-Jul.
10
Emerging Tools for Stroke Prevention in Atrial Fibrillation.心房颤动中风预防的新兴工具
EBioMedicine. 2016 Jan 15;4:26-39. doi: 10.1016/j.ebiom.2016.01.017. eCollection 2016 Feb.